Amber-G
Brand Name(s):Magnaspartate
Indication:Hypomagnesaemia
Rationale:
Considered:Apr-15
Review Date:Apr-20
Comments:
Primary Care must receive a comprehensive treatment plan before prescribing is transfered to the GP including:
Treatment should be initiated under the supervision of a physician experienced in the management of hypomagnesaemia.
A detailed clinical management plan must be provided by the Specialist which includes details on:
(a) Review and followup process
(b) Therapeutic monitoring process
April 2015